O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0.708. It has been cited 111 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.708
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01DK100595
National Institutes of Health
Grant: 5R01DK100595-03
Regulation of Globin Gene Switching by O-GlcNAc Post-Translational Modification
FWCI
6.36
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Additional file 1 of Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Additional file 2 of Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Additional file 2 of Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Additional file 3 of Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Additional file 3 of Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Additional file 1 of Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer
Additional file 1 of Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer